Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18

[1]  Diego Molina,et al.  In silico study of Moxifloxacin derivatives with possible antibacterial activity against a resistant form of DNA gyrase from Porphyromonas gingivalis. , 2018, Archives of oral biology.

[2]  Diego Molina,et al.  A Perspective on Thiazolidinone Scaffold Development as a New Therapeutic Strategy for Toxoplasmosis , 2018, Front. Cell. Infect. Microbiol..

[3]  F. Ayala,et al.  Encephalitis is mediated by ROP18 of Toxoplasma gondii, a severe pathogen in AIDS patients , 2018, Proceedings of the National Academy of Sciences.

[4]  Cynthia Y. He,et al.  Genome-Wide Bimolecular Fluorescence Complementation-Based Proteomic Analysis of Toxoplasma gondii ROP18’s Human Interactome Shows Its Key Role in Regulation of Cell Immunity and Apoptosis , 2018, Front. Immunol..

[5]  J. Gómez‐Marín,et al.  R Script Approach to Infer Toxoplasma Infection Mechanisms From Microarrays and Domain-Domain Protein Interactions , 2017, Bioinformatics and biology insights.

[6]  Kapil Kumar,et al.  Synthetic and medicinal perspective of thiazolidinones: A review. , 2017, Bioorganic chemistry.

[7]  Yongzhong Wang,et al.  A mechanistic study of Toxoplasma gondii ROP18 inhibiting differentiation of C17.2 neural stem cells , 2017, Parasites & Vectors.

[8]  A. Ruiz,et al.  Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: Synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay. , 2017, European journal of medicinal chemistry.

[9]  P. He,et al.  Molluscicidal activity and mechanism of toxicity of a novel salicylanilide ester derivative against Biomphalaria species , 2017, Parasites & Vectors.

[10]  A. Daryani,et al.  A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006–2016) , 2017, Front. Microbiol..

[11]  Xing-Quan Zhu,et al.  Identification of host proteins interacting with Toxoplasma gondii GRA15 (TgGRA15) by yeast two-hybrid system , 2017, Parasites & Vectors.

[12]  C. De Monte,et al.  Synthesis and biological evaluation of anti-Toxoplasma gondii activity of a novel scaffold of thiazolidinone derivatives , 2017, Journal of enzyme inhibition and medicinal chemistry.

[13]  Joachim Müller,et al.  Drug target identification in protozoan parasites , 2016, Expert opinion on drug discovery.

[14]  Pengfei Li,et al.  MCPB.py: A Python Based Metal Center Parameter Builder , 2016, J. Chem. Inf. Model..

[15]  Matthieu Schapira,et al.  Identification of small molecule inhibitors that block the Toxoplasma gondii rhoptry kinase ROP18. , 2016, ACS infectious diseases.

[16]  T. Steinfeldt,et al.  The Toxoplasma gondii rhoptry protein ROP18 is an Irga6‐specific kinase and regulated by the dense granule protein GRA7 , 2015, Cellular microbiology.

[17]  Gladys E. Salcedo,et al.  MSCA: a spectral comparison algorithm between time series to identify protein-protein interactions , 2015, BMC Bioinformatics.

[18]  R. G. C. C. L. Cardenas,et al.  Mendel,MD: a user-friendly online program for clinical exome analysis , 2015, BMC Bioinformatics.

[19]  Juliana Palma,et al.  New insights into the meaning and usefulness of principal component analysis of concatenated trajectories , 2015, J. Comput. Chem..

[20]  C. De Monte,et al.  Design, synthesis and biological characterization of thiazolidin-4-one derivatives as promising inhibitors of Toxoplasma gondii. , 2014, European journal of medicinal chemistry.

[21]  Youyong Li,et al.  Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set. , 2014, Physical chemistry chemical physics : PCCP.

[22]  R. Weiss,et al.  Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies , 2014, Oncogene.

[23]  J. Gómez‐Marín,et al.  Th1 and Th2 immune response to P30 and ROP18 peptides in human toxoplasmosis , 2014, Medical Microbiology and Immunology.

[24]  J. Gómez‐Marín,et al.  Characterization of ROP18 alleles in human toxoplasmosis. , 2014, Parasitology international.

[25]  Dustin J Maly,et al.  Neospora caninum Calcium-Dependent Protein Kinase 1 Is an Effective Drug Target for Neosporosis Therapy , 2014, PloS one.

[26]  Yujun Shen,et al.  Toxoplasma gondii Virulence Factor ROP18 Inhibits the Host NF-κB Pathway by Promoting p65 Degradation* , 2014, The Journal of Biological Chemistry.

[27]  L. Dardenne,et al.  Receptor–ligand molecular docking , 2014, Biophysical Reviews.

[28]  A. Verma,et al.  4-Thiazolidinones: the advances continue…. , 2014, European journal of medicinal chemistry.

[29]  Edward W. Lowe,et al.  Computational Methods in Drug Discovery , 2014, Pharmacological Reviews.

[30]  M. Yaffe,et al.  Structure of the Toxoplasma gondii ROP18 Kinase Domain Reveals a Second Ligand Binding Pocket Required for Acute Virulence* , 2013, The Journal of Biological Chemistry.

[31]  Youyong Li,et al.  Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models. , 2013, The journal of physical chemistry. B.

[32]  D. Hill,et al.  Toxoplasma gondii prevalence in farm animals in the United States. , 2013, International journal for parasitology.

[33]  P. Mortensen,et al.  Toxoplasma gondii infection and self-directed violence in mothers. , 2012, Archives of general psychiatry.

[34]  S. Yokoyama,et al.  Flexibility of the P-loop of Pim-1 kinase: observation of a novel conformation induced by interaction with an inhibitor. , 2012, Acta crystallographica. Section F, Structural biology and crystallization communications.

[35]  M. Yaffe,et al.  The Rhoptry Proteins ROP18 and ROP5 Mediate Toxoplasma gondii Evasion of the Murine, But Not the Human, Interferon-Gamma Response , 2012, PLoS pathogens.

[36]  Steven M. Johnson,et al.  Multiple determinants for selective inhibition of apicomplexan calcium-dependent protein kinase CDPK1. , 2012, Journal of medicinal chemistry.

[37]  D. Lim,et al.  Toxoplasma and Plasmodium protein kinases: roles in invasion and host cell remodelling. , 2011, International journal for parasitology.

[38]  Gerhard Klebe,et al.  DSX: A Knowledge-Based Scoring Function for the Assessment of Protein-Ligand Complexes , 2011, J. Chem. Inf. Model..

[39]  Susan S. Taylor,et al.  Protein kinases: evolution of dynamic regulatory proteins. , 2011, Trends in biochemical sciences.

[40]  G. Kozlov,et al.  A structural overview of the PDI family of proteins , 2010, The FEBS journal.

[41]  Andrea Liesen,et al.  Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles. , 2010, European journal of medicinal chemistry.

[42]  L. Sibley,et al.  Structures of apicomplexan calcium-dependent protein kinases reveal mechanism of activation by calcium , 2010, Nature Structural &Molecular Biology.

[43]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[44]  E. Melo,et al.  Anti-parasitic action and elimination of intracellular Toxoplasma gondii in the presence of novel thiosemicarbazone and its 4-thiazolidinone derivatives. , 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[45]  N. Hakulinen,et al.  Structure-function studies of a Melanocarpus albomyces laccase suggest a pathway for oxidation of phenolic compounds. , 2009, Journal of molecular biology.

[46]  L. Sibley,et al.  Calcium-dependent signaling and kinases in apicomplexan parasites. , 2009, Cell host & microbe.

[47]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[48]  Pascal Benkert,et al.  QMEAN server for protein model quality estimation , 2009, Nucleic Acids Res..

[49]  L. Sibley,et al.  Novel structural and regulatory features of rhoptry secretory kinases in Toxoplasma gondii , 2009, The EMBO journal.

[50]  Y. Guex-Crosier.  Update on the treatment of ocular toxoplasmosis , 2009, International journal of medical sciences.

[51]  G. Müller,et al.  Small-molecule inhibitors binding to protein kinase. Part II: the novel pharmacophore approach of type II and type III inhibition , 2008, Expert opinion on drug discovery.

[52]  G. Müller,et al.  Small-molecule inhibitors binding to protein kinases. Part I: exceptions from the traditional pharmacophore approach of type I inhibition , 2008, Expert opinion on drug discovery.

[53]  Haiming Wang,et al.  ToxoDB: an integrated Toxoplasma gondii database resource , 2007, Nucleic Acids Res..

[54]  G. Labesse,et al.  ROP18 Is a Rhoptry Kinase Controlling the Intracellular Proliferation of Toxoplasma gondii , 2007, PLoS pathogens.

[55]  J. Ajioka,et al.  Polymorphic Secreted Kinases Are Key Virulence Factors in Toxoplasmosis , 2006, Science.

[56]  Paul D Lyne,et al.  Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring. , 2006, Journal of medicinal chemistry.

[57]  Bosco K. Ho,et al.  The Ramachandran plots of glycine and pre-proline , 2005, BMC Structural Biology.

[58]  Janet M. Thornton,et al.  ProFunc: a server for predicting protein function from 3D structure , 2005, Nucleic Acids Res..

[59]  E. D. de Melo,et al.  Synthesis of thiosemicarbazone and 4-thiazolidinone derivatives and their in vitro anti-Toxoplasma gondii activity. , 2005, Bioorganic & medicinal chemistry letters.

[60]  Paula Rahal,et al.  Molecular models of NS3 protease variants of the Hepatitis C virus , 2005, BMC Structural Biology.

[61]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[62]  D. Case,et al.  Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes. , 2003, Journal of molecular biology.

[63]  Heather A. Carlson,et al.  Development of polyphosphate parameters for use with the AMBER force field , 2003, J. Comput. Chem..

[64]  Manuel C. Peitsch,et al.  SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..

[65]  Renxiao Wang,et al.  Comparative evaluation of 11 scoring functions for molecular docking. , 2003, Journal of medicinal chemistry.

[66]  F. Verbraak,et al.  A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis. , 2002, American journal of ophthalmology.

[67]  B. Horta,et al.  The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. , 2002, American journal of ophthalmology.

[68]  Jacopo Tomasi,et al.  Geometry optimization of molecular structures in solution by the polarizable continuum model , 1998, J. Comput. Chem..

[69]  H. Berendsen,et al.  Systematic analysis of domain motions in proteins from conformational change: New results on citrate synthase and T4 lysozyme , 1998, Proteins.

[70]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[71]  L. Weiss,et al.  Chapter 8 - Toxoplasmosis , 2013 .

[72]  Andrea Liesen,et al.  Synthesis, anti-Toxoplasma gondii and antimicrobial activities of benzaldehyde 4-phenyl-3-thiosemicarbazones and 2-[(phenylmethylene)hydrazono]-4-oxo-3-phenyl-5-thiazolidineacetic acids. , 2008, Bioorganic & medicinal chemistry.